SOPHiA GENETICS SA Expense From Share-based Payment Transactions With Employees
SOPHiA GENETICS SA (SOPH) reported Expense From Share-based Payment Transactions With Employees of $93.66 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-03.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees · last filed 2026-03-03
| Period end | Expense From Share-based Payment Transactions With Employees 12 month | Expense From Share-based Payment Transactions With Employees 12 month as first filed |
|---|---|---|
| 2025-12-31 | $93.66M 20-F · filed 2026-03-03 | |
| 2024-12-31 | $86.15M 20-F · filed 2026-03-03 | $83.90M 20-F · filed 2025-03-04 |
| 2023-12-31 | $90.18M 20-F · filed 2026-03-03 | $87.52M 20-F · filed 2024-03-05 |
| 2022-12-31 | $84.43M 20-F · filed 2025-03-04 | |
| 2021-12-31 | $70.69M 20-F · filed 2024-03-05 | |
| 2020-12-31 | $45.07M 20-F · filed 2023-03-07 | |
| 2019-12-31 | $31.45M 20-F · filed 2022-03-15 |